Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
World Journal of Urology
Erschienen in:

27.11.2019 | Topic Paper

How to implement the requirements of a quality assurance system for prostate cancer

verfasst von: Barbara Noris Chiorda, Fabiana Zollo, Tiziana Magnani, Fabio Badenchini, Lucia Gatto, Melanie Claps, Alberto Macchi, Laure Andreoli, Nicola Nicolai, Sergio Villa, Riccardo Valdagni

Erschienen in: World Journal of Urology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In 2003, the German Cancer Society (Deutsche Krebsgesellschaft, DKG) launched a certification program aimed at improving the quality of cancer care. The purpose of this article is to describe the experience of the Prostate Cancer Unit (PCU) at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, in the process towards DKG certification.

Methods

In 2018, PCU decided to apply for certification by adopting DKG catalogue of requirements (CoR) and quality indicators. A multiprofessional working group was established with the aim of acting the necessary steps to meet DKG standards.

Results

Our organizational setting (procedures, personnel) and activities were accurately analyzed, thus outlining strengths and weaknesses, and modified to comply with DKG CoR and indicators. As examples, (1) a quality management plan was developed; (2) measures were taken to strengthen the surgical expertise; (3) cases evaluated in weekly tumor boards were expanded to include surgical cases with pathological risk factors, metastatic, relapsed and castration-resistant patients; (4) a survey was added to the patient-dedicated initiatives already scheduled; (5) the TuDoc software became the tool to register all new cases of prostate cancer patients referred to PCU.

Conclusions

The process of certification requires many efforts but represents a unique opportunity of improving quality of care of prostate cancer patients, making it comparable on an international scale.
Literatur
1.
European Partnership Action Against Cancer consensus group (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer 50:475–480CrossRef
2.
Fennell ML, Das IP, Clauser S et al (2010) The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr 40:72–80CrossRef
3.
Kurpad R, Kim W, Rathmell WK et al (2011) A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? Urol Oncol 29:378–382CrossRef
4.
Kesson EM, Allardice GM, George WD et al (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13722 women. BMJ 344:e2718CrossRef
5.
Jelenc M, Van Hoof E, Albreht T et al (2012) Joint action European partnership for action against cancer. Arch. Public Health 70:24CrossRef
6.
Magnani T, Bracarda S, D'Angelillo RM et al (2019) Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda. Tumori 105:161–167CrossRef
7.
Valdagni R, Albers P, Bangma C et al (2011) The requirements of a specialist prostate cancer unit: a discussion paper from the European School of Oncology. Eur J Cancer 47:1–7CrossRef
8.
Valdagni R, Van Poppel H, Aitchison M et al (2015) Prostate Cancer Unit Initiative in Europe: a position paper by the European School of Oncology. Crit Rev Oncol Hematol 95:133–143CrossRef
9.
10.
NICE Guidance (2019) NICE guidelines prostate cancer. BJU Int. 124:9–26CrossRef
11.
12.
Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629CrossRef
13.
Wolff RF, Ryder S, Bossi A et al (2015) A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. Eur J Cancer 51:2345–2367CrossRef
14.
Potosky AL, Davis WW, Hoffman RM et al (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96:1358–1367CrossRef
15.
Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415–1424CrossRef
16.
Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250–1261CrossRef
17.
Donovan JL, Hamdy FC, Lane JA et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375:1425–1437CrossRef
18.
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef
19.
Wesselman S, Beckmann MW (2014) The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care. Arch Gynecol Obstet 289:7–12CrossRef
20.
Kowalski C, Graeven U, von Kalle C et al (2017) Shifting cancer care towards multidisciplinarity: the cancer center certification program of the German cancer society. BMC Cancer 17:850–859CrossRef
21.
Saghatchian M, Thonon F, Boomsma F et al (2014) Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program. J Oncol Pract 10:e342–e349CrossRef
22.
Saghatchian M, Hummel H, Otter R et al (2008) Organisation of European Cancer Institutes. Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI). Tumori 94:164–171CrossRef
23.
24.
Magnani T, Valdagni R, Salvioni R et al (2012) The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU Int 110:998–1003CrossRef
25.
26.
Spencer BA, Miller DC, Litwin MS et al (2008) Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol 26:3735–3742CrossRef
27.
Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079–1092CrossRef
Metadaten
Titel
How to implement the requirements of a quality assurance system for prostate cancer
verfasst von
Barbara Noris Chiorda
Fabiana Zollo
Tiziana Magnani
Fabio Badenchini
Lucia Gatto
Melanie Claps
Alberto Macchi
Laure Andreoli
Nicola Nicolai
Sergio Villa
Riccardo Valdagni
Publikationsdatum
27.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 1/2021
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-03024-x

Weitere Artikel der Ausgabe 1/2021

Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients

  • Topic Paper

Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study

  • Original Article

Comparison of super-mini-PCNL and flexible ureteroscopy for the management of upper urinary tract calculus (1–2 cm) in children

  • Original Article

Holmium laser enucleation of the prostate for very large benign prostatic hyperplasia (≥ 200 cc)

  • Original Article

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan

  • Original Article

Development of bioabsorbable zinc–magnesium alloy wire and validation of its application to urinary tract surgeries

  • Original Article

Neu im Fachgebiet Urologie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Wechsel von Zugangsroute und Biopsiesteuerung: Erfahrungen eines Zentrums

Geht der Switch zur transperinealen gezielten Prostatabiopsie auf Kosten der diagnostischen Qualität? Nein, urteilen norwegische Urologinnen und Urologen nach Durchsicht von Daten aus ihrer Einrichtung.

Warum werden Hodenprothesen so selten angeboten?

Forschende aus Großbritannien haben untersucht, wie häufig eine Hodenprothese bei krebsbedingter radikaler Orchidektomie angeboten wird. Vor allem die Gründe, warum kein Implantat zur Wahl gestellt wird, sind erstaunlich. 

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise